Once the data warehouse is assembled, its customers will likely

Size: px
Start display at page:

Download "Once the data warehouse is assembled, its customers will likely"

Transcription

1 Clinical Data Warehouse Development with Base SAS Software and Common Desktop Tools Patricia L. Gerend, Genentech, Inc., South San Francisco, California ABSTRACT By focusing on the information needed by customers, it is possible to develop an effective clinical data warehouse using tools that already exist on a typical clinical programmer s desktop. The common tools base SAS, SAS macro language, SAS/FSP, UNIX, Microsoft Word, and file transfer protocol (FTP) can be harnessed to implement dependencies, scheduling, metadata dictionaries, documentation, and data mart generation. INTRODUCTION There has been considerable focus in recent years on optimal development of clinical data warehouses. As global pressure on timetables for new biotech and pharmaceutical products increases, so does the corresponding need to have meaningful clinical trial information available at the fingertips. In general, clinical trial data is entered into operational databases in a normalized fashion; data is stored in many different files in order to reduce redundancy and resulting update anomalies. While this approach has traditionally been successful for data entry, it has proven difficult for data analysis and reporting, which benefit from having all needed data in the same file for easy access. It is the need to have related data stored together as well as the need for derived information that drive the development of a data warehouse. Catering to the ways in which a person will want to examine the data should be the prime focus of development. In so doing, the developer is free to select whichever tools accommodate this focus, be they common desktop tools or sophisticated data warehouse products. It is often the case that common tools are inexpensive and do not require a significant learning curve, while sophisticated products are expensive and time-consuming to learn. However, sophisticated products can offer a level of process and output cohesion that is lacking in the less developed approaches. This paper describes a method for developing a data warehouse of clinical trials subject data that makes use of the following desktop tools common to most clinical programmers: Base SAS SAS macro language SAS/FSP UNIX Microsoft Word FTP Tips for developing a glue that holds the various processes and tasks together are provided. Once the data warehouse is assembled, its customers will likely

2 include the following: company scientists and statisticians, company programmers, Food and Drug Administration (FDA) reviewers, outside investigators, and industry/academic collaborators. These customers will be able to easily access the data with numerous tools common to reviewers, such as SAS, the SAS System Viewer, JMP, SPlus, and Microsoft Excel. QUALITIES OF A GOOD DATA WAREHOUSE Since the goal of a data warehouse is to provide information to customers, the best approach for its design is to focus on what the customers need before addressing which tools will be used to provide it. Below is a table summarizing the major user needs as well as features a developer must implement to meet these needs: Figure 1. Customer Requirements Customer Developer Must Do Needs Ease of use Good database design Good documentation Appropriate data marts Accuracy Dependency control Code validation Timeliness Scheduled data refreshes These user requirements and ways of achieving them are addressed in detail below. CUSTOMER NEEDS: EASE OF USE As with any product, the easier it is to use, the more likely customers will use it and do so correctly. It is critical that the data warehouse include information that customers need in structures that are easy to assimilate as well as documentation that helps them understand the data. Database Design Requirements The following requirements exist for designing the data warehouse: Provide appropriate and relevant data content Comply with FDA electronic submission guidelines (although this is not strictly required for information not being sent to the FDA, the guidelines are very reasonable for any clinical data warehouse) Mimic case report forms (CRFs) when grouping variables to match the customers preconception of the data s structure Minimize/eliminate the need to merge data sets since this step is quite error-prone for nonprofessional programmers Add stratification parameters to all data sets, such as age, sex, race, and treatment group Create a large one-recordper-subject data set with baseline and outcome information Minimize the need for calculations since this can also be error-prone and wastes the time of the customer Calculate a study day variable for all data sets Calculate other anticipated derivations Use consistent names and structures

3 Define consistent visit identifiers across all data sets Assign meaningful names to variables and data sets Eliminate housekeeping variables such as data entry operator Keep data sets comprehensive by including subsetting flags since it is easier to subset a data set when necessary that it is to merge or concatenate data sets when necessary Keep related data sets in the same directory so they can be found easily Implementation The requirements itemized above can be implemented through the following methods: Develop data standards for items involved in collecting, storing, and analyzing the data: Case report forms Operational database structures and names Derived data structures and names Standard data transformation programs that use base SAS data steps and procedures and the SAS macro language Utilize subsetting flags and standard directory structures to facilitate creation of data marts: Subsets within clinical studies Supersets across clinical studies Documentation Requirements By following the recommendations above for database design, the data will be self-documenting to the extent possible. However, since a data warehouse is not prose, this additional documentation of its content is needed: Alphabetized listing of all data sets, variables, variable attributes, labels, formats, and format values (Figure 3.) English documentation of derivation methods (Figure 4.) Data tips for nuances and major analyses Implementation The documentation requirements can be implemented in the following ways: Add labels to all data sets and variables Attach formats to all coded values Produce a report-quality listing of metadata using SAS PROC CONTENTS and PROC REPORT Type derivation methods into an MS/Word table Develop a derived data dictionary using base SAS and SAS/FSP to aid the data warehouse developer Data Marts Requirements It is common to encounter customers who don t need all the data from a given study as well as customers who need data from multiple studies. The data warehouse developer can tailor the delivered data sets to the needs of the customer: Limit data to customer needs; e.g., pharmacokinetic data only Store related data sets in the same directory

4 Implementation The following techniques make creation of data marts easy: Utilize subsetting flags to limit data to relevant subjects Create supersets of data across clinical studies, such as integrated safety databases, using standard data and directory structures Use standard directory structures to reduce confusion CUSTOMER NEEDS: ACCURACY Requirements At least as important as any other customer requirement is that for accurate data. The FDA has regulations governing data accuracy, and common sense supports this concept. By addressing the following requirements, accurate data can be produced: Comply with the FDA s Good Clinical Practices (GCPs) Validate software Ensure dependency control Implementation The following list outlines ways in which the accuracy requirements can be achieved: Develop and practice a software validation Standard Operating Procedure (SOP) Utilize the UNIX makefile Program and document dependencies among data sets and programs (Figure 5.) Enforce these dependencies by executing the UNIX makefile after any change to data or programs CUSTOMER NEEDS: TIMELINESS Requirements A well-designed and accurate data warehouse will not make much of an impact if its delivery is not timely. The following requirements exist for ensuring that the date warehouse is ready for customer access: Data appropriately clean when delivered Data appropriately current Implementation To implement timeliness of development and delivery of the data warehouse, the following procedures are recommended: Determine periodicity of cleaning and refreshing data At regular intervals At specific milestones Execute UNIX makefile at appropriate time to refresh data DATA WAREHOUSE COHESION AND TRACKING Unlike formal data warehouse products, where pulldown menus and component dependency tracking may be readily available, the use of generic software packages precludes any automatic tracking and consistency checking among data warehouse components. The developer must institute such monitoring themselves. Creation of a checklist is recommended in which each step of the process is identified and acknowledged as completed. Development of programs that check consistency is also beneficial.

5 The following items should exist in the completion checklist: Extract data from operational database Add stratification variables, study day, and common visit identifiers to all data sets Document derivations for analysis data sets Code and validate analysis data sets Update metadata database if needed Code UNIX makefile Produce detailed listing of data set variables and their metadata Author data usage tips If the data warehouse is to be submitted to the FDA, conversion of SAS data sets to transport format and validation of this process should be added to the checklist. DATA ACCESS AND REVIEW METHODS There are numerous data review packages that can easily access SAS data sets or transport files. Company and FDA scientists are generally familiar with at least one of these products. According to current FDA electronic submission guidelines, SAS transport files of clinical study data are to be delivered. It is recommended that the sponsor company provide the FDA with sample code for converting transport files back into SAS data sets if this process is needed. Figure 2. below identifies some of the data review products that are in use by company and FDA reviewers as well as the processes needed to make the data accessible to these tools. Figure 2. Data Access Products and Methods Access Product Operating System Used Data Type Used SAS Desktop or SAS data sets SAS System Viewer Data Conversion and Transfer Methods from SAS Data Sets on UNIX FTP to desktop if not using SAS on UNIX UNIX Desktop SAS data sets FTP to desktop JMP Desktop SAS transport files SAS proc copy, FTP to desktop SPlus Desktop or UNIX SAS data sets FTP to desktop if not using SPlus on UNIX Excel Desktop Excel spreadsheets FTP to desktop, SAS import/export wizard

6 CONCLUSIONS Software tools common on the desktops of most clinical programmers can be easily harnessed for development of a clinical data warehouse, alleviating the need to invest money and time into a sophisticated data warehouse product. Strategic use of these common tools can effectively meet the FDA s GCP and electronic submission requirements, reduce additional expenditures for software, and reduce the data warehouse development learning curve. These features aid the company s bottom line not only in conserving funds for software, but also by facilitating flexible training, hiring, and transfer of staff. The major disadvantage of using common tools rather than a formal data warehouse product is that there is no automatic tracking of technical tasks and processes performed. This issue can be addressed by creating a list of tasks and processes, and checking off each one as it is completed. TRADEMARK CITATION SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. indicates USA registration. Other brand and product names are registered trademarks or trademarks of their respective companies. CONTACT INFORMATION Author: Patricia L. Gerend Senior Manager, Statistical Programming Address: Statistical Programming Department Mailstop #66 Genentech, Inc. 1 DNA Way South San Francisco, California gerend.patricia@gene.com

7 Figure 3. Detailed Listing of SAS Data Set Variables Data Set STAT: Statistical Analysis File with Baseline and Outcome Information Variable Name Description Type Length Format Name Format Value Format Decode AGE Age at randomization Numeric 8 BESTRESP Best response on study Numeric 8 RESPFMT 1 Complete response 2 Partial response 3 Stable disease 4 Progressive disease 5 Unable to determine CADX Cancer diagnosis Numeric 8 CADXFMT 1 Superficial 2 Visceral PCHEMO Prior chemotherapy (n/y) Numeric 8 NOYES 0 No 1 Yes 2 Not available PHORM Prior hormonal therapy (n/y) Numeric 8 NOYES 0 No 1 Yes 2 Not available PRAD Prior radiotherapy (n/y) Numeric 8 NOYES 0 No 1 Yes 2 Not available TX Treatment on study Numeric 8 TXFMT 1 Active 2 Control

8 Figure 4. Derivation Methods for Statistical Analysis File STAT Variable Name Variable Label Derivation Method age Age at randomization (years) Number of full years from birthdate (demog.birthdt) to date of randomization (stat.strtdate) bestresp Best response on study Set to best response on study from independent review committee (bestrev) when available; otherwise, set to best response on study from investigator (bestinv) cadx Cancer diagnosis Directly from cahx.cadx pchemo Prior chemotherapy (n/y) Set to 1 (yes) if patient received any chemotherapy (ptx.ptxdes=3) in the adjuvant setting (ptx.ptxcode=1) phorm Prior hormonal therapy (n/y) Set to 1 (yes) if patient received any hormonal therapy (ptx.ptxdes=2) in the adjuvant setting (ptx.ptxcode=1) prad Prior radiotherapy (n/y) Set to 1 (yes) if patient received any radiotherapy (ptx.ptxany=1 and ptx.ptxdes=1) in the adjuvant setting (ptx.ptxcode=1) tx Treatment on study Directly from randivrs.tx

9 Figure 5. Sample UNIX Makefile ################################################################ ### UNIX Makefile for oncology study ### ### ### ### Raw transport files are converted to SAS data sets. ### ### Analysis files (data warehouse) are created. ### ### Listings, tables, and graphs are produced. ### ### Dependencies among all input, output, and programs are coded here. ### ### ### ### Programmer: Jane Doe 7/31/2000 ### ################################################################ # All systems addressed by the makefile system: \ rawdata \ warehouse \ formats \ listings \ tables \ graphs # end of system # Excerpt from data warehouse section of makefile # #===========================================# warehouse: \../outdata/stat.ssd01 : \ stat.sas \ rawdata/cahx.ssd01 \ rawdata/demog.ssd01 \ rawdata/ptx.ssd01 \ rawdata/randivrs.ssd01 sas stat.sas # end of warehouse

10

One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc.

One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc. One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc. Chapel Hill, NC RHelms@RhoWorld.com www.rhoworld.com Presented to ASA/JSM: San Francisco, August 2003 One-PROC-Away

More information

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES Developing Integrated Summary of Safety Database using CDISC Standards Rajkumar Sharma, Genentech Inc., A member of the Roche Group, South San Francisco, CA ABSTRACT Most individual trials are not powered

More information

Paper A Simplified and Efficient Way to Map Variable Attributes of a Clinical Data Warehouse

Paper A Simplified and Efficient Way to Map Variable Attributes of a Clinical Data Warehouse Paper 117-28 A Simplified and Efficient Way to Map Variable Attributes of a Clinical Data Warehouse Yanyun Shen, Genentech, Inc., South San Francisco ABSTRACT In the pharmaceutical industry, pooling a

More information

Tools to Facilitate the Creation of Pooled Clinical Trials Databases

Tools to Facilitate the Creation of Pooled Clinical Trials Databases Paper AD10 Tools to Facilitate the Creation of Pooled Clinical Trials Databases Patricia Majcher, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, NJ ABSTRACT Data collected from

More information

A SAS and Java Application for Reporting Clinical Trial Data. Kevin Kane MSc Infoworks (Data Handling) Limited

A SAS and Java Application for Reporting Clinical Trial Data. Kevin Kane MSc Infoworks (Data Handling) Limited A SAS and Java Application for Reporting Clinical Trial Data Kevin Kane MSc Infoworks (Data Handling) Limited Reporting Clinical Trials Is Resource Intensive! Reporting a clinical trial program for a new

More information

How to review a CRF - A statistical programmer perspective

How to review a CRF - A statistical programmer perspective Paper DH07 How to review a CRF - A statistical programmer perspective Elsa Lozachmeur, Novartis Pharma AG, Basel, Switzerland ABSTRACT The design of the Case Report Form (CRF) is critical for the capture

More information

An Introduction to Analysis (and Repository) Databases (ARDs)

An Introduction to Analysis (and Repository) Databases (ARDs) An Introduction to Analysis (and Repository) TM Databases (ARDs) Russell W. Helms, Ph.D. Rho, Inc. Chapel Hill, NC RHelms@RhoWorld.com www.rhoworld.com Presented to DIA-CDM: Philadelphia, PA, 1 April 2003

More information

PharmaSUG Paper PO22

PharmaSUG Paper PO22 PharmaSUG 2015 - Paper PO22 Challenges in Developing ADSL with Baseline Data Hongyu Liu, Vertex Pharmaceuticals Incorporated, Boston, MA Hang Pang, Vertex Pharmaceuticals Incorporated, Boston, MA ABSTRACT

More information

How to write ADaM specifications like a ninja.

How to write ADaM specifications like a ninja. Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation

More information

CDISC SDTM and ADaM Real World Issues

CDISC SDTM and ADaM Real World Issues CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC

More information

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database PharmaSUG 2017 - Paper DS13 Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database ABSTRACT Cori Kramer, Ragini Hari, Keith Shusterman, Chiltern When SDTM

More information

Integrating SAS with Open Source. Software

Integrating SAS with Open Source. Software Integrating SAS with Open Source Software Jeremy Fletcher Informatics Specialist Pharma Global Informatics F. Hoffmann-La Roche F. Hoffmann La Roche A Global Healthcare Leader One of the leading research-intensive

More information

Clinical Data Model and FDA Submissions

Clinical Data Model and FDA Submissions Clinical Data Model and FDA Submissions Shy Kumar, Datafarm, Inc., Marlboro, MA Gajanan Bhat, Boston Scientific Corporation, Natick, MA ABSTRACT Development of data model in clinical trial management environment

More information

Creating a Patient Profile using CDISC SDTM Marc Desgrousilliers, Clinovo, Sunnyvale, CA Romain Miralles, Clinovo, Sunnyvale, CA

Creating a Patient Profile using CDISC SDTM Marc Desgrousilliers, Clinovo, Sunnyvale, CA Romain Miralles, Clinovo, Sunnyvale, CA Creating a Patient Profile using CDISC SDTM Marc Desgrousilliers, Clinovo, Sunnyvale, CA Romain Miralles, Clinovo, Sunnyvale, CA ABSTRACT CDISC SDTM data is the standard format requested by the FDA for

More information

Office of Human Research

Office of Human Research Office of Human Research JeffTrial End-User Training Document Regulatory Coordinator Training for Non-Oncology personnel Office of Human Research 8/16/2013 Ver. 1.0 Contents The REG Role: Completing Basic

More information

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets PharmaSUG2011 Paper CD17 Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets Elizabeth Li, PharmaStat LLC, Newark, California Linda Collins, PharmaStat

More information

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

Programming checks: Reviewing the overall quality of the deliverables without parallel programming PharmaSUG 2016 Paper IB04 Programming checks: Reviewing the overall quality of the deliverables without parallel programming Shailendra Phadke, Baxalta US Inc., Cambridge MA Veronika Csom, Baxalta US Inc.,

More information

Standard Safety Visualization Set-up Using Spotfire

Standard Safety Visualization Set-up Using Spotfire Paper SD08 Standard Safety Visualization Set-up Using Spotfire Michaela Mertes, F. Hoffmann-La Roche, Ltd., Basel, Switzerland ABSTRACT Stakeholders are requesting real-time access to clinical data to

More information

Why organizations need MDR system to manage clinical metadata?

Why organizations need MDR system to manage clinical metadata? PharmaSUG 2018 - Paper SS-17 Why organizations need MDR system to manage clinical metadata? Abhinav Jain, Ephicacy Consulting Group Inc. ABSTRACT In the last decade, CDISC standards undoubtedly have transformed

More information

Creating Forest Plots Using SAS/GRAPH and the Annotate Facility

Creating Forest Plots Using SAS/GRAPH and the Annotate Facility PharmaSUG2011 Paper TT12 Creating Forest Plots Using SAS/GRAPH and the Annotate Facility Amanda Tweed, Millennium: The Takeda Oncology Company, Cambridge, MA ABSTRACT Forest plots have become common in

More information

Figure 1. Table shell

Figure 1. Table shell Reducing Statisticians Programming Load: Automated Statistical Analysis with SAS and XML Michael C. Palmer, Zurich Biostatistics, Inc., Morristown, NJ Cecilia A. Hale, Zurich Biostatistics, Inc., Morristown,

More information

Database Systems: Design, Implementation, and Management Tenth Edition. Chapter 1 Database Systems

Database Systems: Design, Implementation, and Management Tenth Edition. Chapter 1 Database Systems Database Systems: Design, Implementation, and Management Tenth Edition Chapter 1 Database Systems Objectives In this chapter, you will learn: The difference between data and information What a database

More information

PharmaSUG Paper PO10

PharmaSUG Paper PO10 PharmaSUG 2013 - Paper PO10 How to make SAS Drug Development more efficient Xiaopeng Li, Celerion Inc., Lincoln, NE Chun Feng, Celerion Inc., Lincoln, NE Peng Chai, Celerion Inc., Lincoln, NE ABSTRACT

More information

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA PharmaSug2016- Paper HA03 Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA ABSTRACT A composite endpoint in a Randomized Clinical Trial

More information

JMP Clinical. Release Notes. Version 5.0

JMP Clinical. Release Notes. Version 5.0 JMP Clinical Version 5.0 Release Notes Creativity involves breaking out of established patterns in order to look at things in a different way. Edward de Bono JMP, A Business Unit of SAS SAS Campus Drive

More information

Design of Case Report Forms. Case Report Form. Purpose. ..CRF Official clinical data-recording document or tool used in a clinical study

Design of Case Report Forms. Case Report Form. Purpose. ..CRF Official clinical data-recording document or tool used in a clinical study Design of Case Report Forms David W. Mailhot February 23, 2010 Case Report Form..CRF Official clinical data-recording document or tool used in a clinical study PAPER RDC/RDE (Remote Data Capture, Remote

More information

How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation

How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation Paper DH05 How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation Judith Goud, Akana, Bennekom, The Netherlands Priya Shetty, Intelent, Princeton, USA ABSTRACT The traditional

More information

Applying ADaM Principles in Developing a Response Analysis Dataset

Applying ADaM Principles in Developing a Response Analysis Dataset PharmaSUG2010 Paper CD03 Applying ADaM Principles in Developing a Response Analysis Dataset Mei Dey, Merck & Co., Inc Lisa Pyle, Merck & Co., Inc ABSTRACT The Clinical Data Interchange Standards Consortium

More information

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched

More information

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA PharmaSUG 2015 - Paper IB09 Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA ABSTRACT A submission to FDA for an NDA (New Drug Application) or

More information

Customizing SAS Data Integration Studio to Generate CDISC Compliant SDTM 3.1 Domains

Customizing SAS Data Integration Studio to Generate CDISC Compliant SDTM 3.1 Domains Paper AD17 Customizing SAS Data Integration Studio to Generate CDISC Compliant SDTM 3.1 Domains ABSTRACT Tatyana Kovtun, Bayer HealthCare Pharmaceuticals, Montville, NJ John Markle, Bayer HealthCare Pharmaceuticals,

More information

esource Initiative ISSUES RELATED TO NON-CRF DATA PRACTICES

esource Initiative ISSUES RELATED TO NON-CRF DATA PRACTICES esource Initiative ISSUES RELATED TO NON-CRF DATA PRACTICES ISSUES RELATED TO NON-CRF DATA PRACTICES Introduction Non-Case Report Form (CRF) data are defined as data which include collection and transfer

More information

From Manual to Automatic with Overdrive - Using SAS to Automate Report Generation Faron Kincheloe, Baylor University, Waco, TX

From Manual to Automatic with Overdrive - Using SAS to Automate Report Generation Faron Kincheloe, Baylor University, Waco, TX Paper 152-27 From Manual to Automatic with Overdrive - Using SAS to Automate Report Generation Faron Kincheloe, Baylor University, Waco, TX ABSTRACT This paper is a case study of how SAS products were

More information

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA PharmaSUG 2018 - Paper EP15 Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA Ellen Lin, Wei Cui, Ran Li, and Yaling Teng Amgen Inc, Thousand Oaks, CA ABSTRACT The

More information

Material covered in the Dec 2014 FDA Binding Guidances

Material covered in the Dec 2014 FDA Binding Guidances Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material

More information

Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata

Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata Paper SD02 Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata Dr. Philippe Verplancke, XClinical GmbH, Munich, Germany ABSTRACT define.xml is often created at the end of

More information

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data An Approach to CDISC SDTM Implementation for Clinical Trials Data William T. Chen, Merck Research Laboratories, Rahway, NJ Margaret M. Coughlin, Merck Research Laboratories, Rahway, NJ ABSTRACT The Clinical

More information

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India Paper CD15 PhUSE 2016 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences,

More information

Creating an ADaM Data Set for Correlation Analyses

Creating an ADaM Data Set for Correlation Analyses PharmaSUG 2018 - Paper DS-17 ABSTRACT Creating an ADaM Data Set for Correlation Analyses Chad Melson, Experis Clinical, Cincinnati, OH The purpose of a correlation analysis is to evaluate relationships

More information

The first approach to accessing pathology diagnostic information is the use of synoptic worksheets produced by the

The first approach to accessing pathology diagnostic information is the use of synoptic worksheets produced by the ABSTRACT INTRODUCTION Expediting Access to Critical Pathology Data Leanne Goldstein, City of Hope, Duarte, CA Rebecca Ottesen, City of Hope, Duarte, CA Julie Kilburn, City of Hope, Duarte, CA Joyce Niland,

More information

User Guide 16-Mar-2018

User Guide 16-Mar-2018 16-Mar-2018 This document is freely distributable Identification Authors Name Organization Title TMF User Guide and Implementation Guide Sub-Team Version History Version Steering Committee Approval Date

More information

How to handle different versions of SDTM & DEFINE generation in a Single Study?

How to handle different versions of SDTM & DEFINE generation in a Single Study? Paper CD15 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai,

More information

Practical Approaches for Using the CTN Datashare: Proposing Parameters, Creating Data Tables, and Analyzing Results.

Practical Approaches for Using the CTN Datashare: Proposing Parameters, Creating Data Tables, and Analyzing Results. Practical Approaches for Using the CTN Datashare: Proposing Parameters, Creating Data Tables, and Analyzing Results Abigail Matthews The EMMES Corporation June 14, 2014 amatthews@emmes.com Outline How

More information

Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization

Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization Vicki Seyfert-Margolis, PhD Senior Advisor, Science Innovation and Policy Food and Drug Administration IOM Sharing Clinical Research

More information

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits

More information

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Standardizing FDA Data to Improve Success in Pediatric Drug Development Paper RA01 Standardizing FDA Data to Improve Success in Pediatric Drug Development Case Study: Harmonizing Hypertensive Pediatric Data across Sponsors using SAS and the CDISC Model Julie Maddox, SAS Institute,

More information

Implementing CDISC Using SAS. Full book available for purchase here.

Implementing CDISC Using SAS. Full book available for purchase here. Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models

More information

DATA WAREHOUSING. a solution for the Caribbean

DATA WAREHOUSING. a solution for the Caribbean DATA WAREHOUSING a solution for the Caribbean a Presentation & Proposal to the 11th Caribbean Conference on National Health Financing Initiatives October 2016 Bonaire, Caribisc Nederland acknowledgements

More information

SAS/Warehouse Administrator Usage and Enhancements Terry Lewis, SAS Institute Inc., Cary, NC

SAS/Warehouse Administrator Usage and Enhancements Terry Lewis, SAS Institute Inc., Cary, NC SAS/Warehouse Administrator Usage and Enhancements Terry Lewis, SAS Institute Inc., Cary, NC ABSTRACT SAS/Warehouse Administrator software makes it easier to build, maintain, and access data warehouses

More information

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA PharmaSUG 2017 - Paper DS23 The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA ABSTRACT Since FDA released the Analysis

More information

Data Integrity through DEFINE.PDF and DEFINE.XML

Data Integrity through DEFINE.PDF and DEFINE.XML Data Integrity through DEFINE.PDF and DEFINE.XML Sy Truong, Meta Xceed, Inc, Fremont, CA ABSTRACT One of the key questions asked in determining if an analysis dataset is valid is simply, what did you do

More information

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure. PRMS Amendment Submission Policy

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure. PRMS Amendment Submission Policy University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Policy and Procedure PRMS Amendment Submission Policy PRMS Procedure for Submitting Institutional Protocol Amendments

More information

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples PharmaSUG 2017 - Paper DS06 Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples Keith Shusterman, Chiltern; Prathima Surabhi, AstraZeneca; Binoy Varghese, Medimmune ABSTRACT

More information

Easy CSR In-Text Table Automation, Oh My

Easy CSR In-Text Table Automation, Oh My PharmaSUG 2018 - Paper BB-09 ABSTRACT Easy CSR In-Text Table Automation, Oh My Janet Stuelpner, SAS Institute Your medical writers are about to embark on creating the narrative for the clinical study report

More information

Patricia Guldin, Merck & Co., Inc., Kenilworth, NJ USA

Patricia Guldin, Merck & Co., Inc., Kenilworth, NJ USA SESUG 2015 Paper AD-35 Programming Compliance Made Easy with a Time Saving Toolbox Patricia Guldin, Merck & Co., Inc., Kenilworth, NJ USA ABSTRACT Programmers perform validation in accordance with established

More information

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments... From Implementing CDISC Using SAS. Full book available for purchase here. Contents About This Book... xi About The Authors... xvii Acknowledgments... xix Chapter 1: Implementation Strategies... 1 Why CDISC

More information

WRITE SAS CODE TO GENERATE ANOTHER SAS PROGRAM

WRITE SAS CODE TO GENERATE ANOTHER SAS PROGRAM WRITE SAS CODE TO GENERATE ANOTHER SAS PROGRAM A DYNAMIC WAY TO GET YOUR DATA INTO THE SAS SYSTEM Linda Gau, ProUnlimited, South San Francisco, CA ABSTRACT In this paper we introduce a dynamic way to create

More information

Integrated Safety Reporting Anemone Thalmann elba - GEIGY Ltd (PH3.25), Basel

Integrated Safety Reporting Anemone Thalmann elba - GEIGY Ltd (PH3.25), Basel ntegrated Safety Reporting Anemone Thalmann elba - GEGY Ltd (PH3.25), Basel Abstract: Most of the regulatory health authorities approving pharmaceutical products consider the ntegrated Safety Summary to

More information

OnCore Enterprise Research. Subject Administration Full Study

OnCore Enterprise Research. Subject Administration Full Study OnCore Enterprise Research Subject Administration Full Study Principal Investigator Clinical Research Coordinator June 2017 P a g e 1 This page is intentionally blank. P a g e 2 Table of Contents What

More information

CFB: A Programming Pattern for Creating Change from Baseline Datasets Lei Zhang, Celgene Corporation, Summit, NJ

CFB: A Programming Pattern for Creating Change from Baseline Datasets Lei Zhang, Celgene Corporation, Summit, NJ Paper TT13 CFB: A Programming Pattern for Creating Change from Baseline Datasets Lei Zhang, Celgene Corporation, Summit, NJ ABSTRACT In many clinical studies, Change from Baseline analysis is frequently

More information

PharmaSUG. companies. This paper. will cover how. processes, a fairly linear. before moving. be carried out. Lifecycle. established.

PharmaSUG. companies. This paper. will cover how. processes, a fairly linear. before moving. be carried out. Lifecycle. established. PharmaSUG 2016 - Paper PO17 Standards Implementationn & Governance: Carrot or Stick? Julie Smiley, Akana, San Antonio, Texas Judith Goud, Akana, Bennekom, Netherlands ABSTRACT With the looming FDA mandate

More information

ehepqual- HCV Quality of Care Performance Measure Program

ehepqual- HCV Quality of Care Performance Measure Program NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE ehepqual- HCV Quality of Care Performance Measure Program USERS GUIDE A GUIDE FOR PRIMARY CARE AND HEPATITIS C CARE PROVIDERS * * For use with ehepqual,

More information

One Project, Two Teams: The Unblind Leading the Blind

One Project, Two Teams: The Unblind Leading the Blind ABSTRACT PharmaSUG 2017 - Paper BB01 One Project, Two Teams: The Unblind Leading the Blind Kristen Reece Harrington, Rho, Inc. In the pharmaceutical world, there are instances where multiple independent

More information

Clinical Metadata Metadata management with a CDISC mindset

Clinical Metadata Metadata management with a CDISC mindset Paper SI02 Clinical Metadata Metadata management with a CDISC mindset Andrew Ndikom, Clinical Metadata, London, United Kingdom Liang Wang, Clinical Metadata, London, United Kingdom ABSTRACT Metadata is

More information

Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc.

Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc. PharmaSUG2011 - Paper DM03 Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc., TX ABSTRACT In the Clinical trials data analysis

More information

Reviewers Guide on Clinical Trials

Reviewers Guide on Clinical Trials Reviewers Guide on Clinical Trials Office of Research Integrity & Compliance Version 2 Updated: June 26, 2017 This document is meant to help board members conduct reviews for Full Board: Clinical Trial

More information

Pooling strategy of clinical data

Pooling strategy of clinical data Pooling strategy of clinical data Abraham Yeh, Xiaohong (Grace) Zhang, Shin-Ru Wang, Novartis Pharmaceuticals Corporation, East Hanover, NJ ABSTRACT Pooling of clinical data is used by all pharmaceutical

More information

Guiding the Way to XML Data Exchange Implementation

Guiding the Way to XML Data Exchange Implementation Guiding the Way to XML Data Exchange Implementation Isaac Hands, MPH Lead Software Architect, Kentucky Cancer Registry Chair, NAACCR XML Data Exchange Workgroup Representative-at-Large, NAACCR Board of

More information

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes ABSTRACT PharmaSUG 2014 PO16 Automation of ADAM set Creation with a Retrospective, Prospective and Pragmatic Process Karin LaPann, MSIS, PRA International, USA Terek Peterson, MBA, PRA International, USA

More information

Common Statistical Analysis Plan (SAP) Frequently Asked Questions

Common Statistical Analysis Plan (SAP) Frequently Asked Questions Last Updated 4-Nov-2018 Topics 1 Stakeholder Input to Common SAP Template Development... 2 2 Template Content... 2 3 Implementation of the Common SAP template by the Sponsor... 55 4 Updates to the Common

More information

An Efficient Solution to Efficacy ADaM Design and Implementation

An Efficient Solution to Efficacy ADaM Design and Implementation PharmaSUG 2017 - Paper AD05 An Efficient Solution to Efficacy ADaM Design and Implementation Chengxin Li, Pfizer Consumer Healthcare, Madison, NJ, USA Zhongwei Zhou, Pfizer Consumer Healthcare, Madison,

More information

Maximizing Statistical Interactions Part II: Database Issues Provided by: The Biostatistics Collaboration Center (BCC) at Northwestern University

Maximizing Statistical Interactions Part II: Database Issues Provided by: The Biostatistics Collaboration Center (BCC) at Northwestern University Maximizing Statistical Interactions Part II: Database Issues Provided by: The Biostatistics Collaboration Center (BCC) at Northwestern University While your data tables or spreadsheets may look good to

More information

Global Checklist to QC SDTM Lab Data Murali Marneni, PPD, LLC, Morrisville, NC Sekhar Badam, PPD, LLC, Morrisville, NC

Global Checklist to QC SDTM Lab Data Murali Marneni, PPD, LLC, Morrisville, NC Sekhar Badam, PPD, LLC, Morrisville, NC PharmaSUG 2018 Paper DS-13 Global Checklist to QC SDTM Lab Data Murali Marneni, PPD, LLC, Morrisville, NC Sekhar Badam, PPD, LLC, Morrisville, NC ABSTRACT Laboratory data is one of the primary datasets

More information

Experiences in Data Quality

Experiences in Data Quality Experiences in Data Quality MIT IQIS 2010 Annette Pence July 14-16, 2010 Approved for Public Release: 10-0686 Distribution Unlimited As a public interest company, MITRE works in partnership with the government

More information

An Alternate Way to Create the Standard SDTM Domains

An Alternate Way to Create the Standard SDTM Domains PharmaSUG 2018 - Paper DS-12 ABSTRACT An Alternate Way to Create the Standard SDTM Domains Sunil Kumar Pusarla, Omeros Corporation Sponsors who initiate clinical trials after 2016-12-17 are required to

More information

BioInformatics A Roadmap To Success. Data Management Plans. Wes Rountree Associate Director of Data Management Family Health International

BioInformatics A Roadmap To Success. Data Management Plans. Wes Rountree Associate Director of Data Management Family Health International BioInformatics A Roadmap To Success Data Management Plans Wes Rountree Associate Director of Data Management Family Health International What is a Data Management Plan? A document that describes how clinical

More information

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components PharmaSUG 2017 - Paper AD19 SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components Walter Hufford, Vincent Guo, and Mijun Hu, Novartis Pharmaceuticals Corporation ABSTRACT

More information

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method PharmaSUG 2015 - Paper AD01 The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA ABSTRACT

More information

Data Science Services Dirk Engfer Page 1 of 5

Data Science Services Dirk Engfer Page 1 of 5 Page 1 of 5 Services SAS programming Conform to CDISC SDTM and ADaM within clinical trials. Create textual outputs (tables, listings) and graphical output. Establish SAS macros for repetitive tasks and

More information

Module I: Clinical Trials a Practical Guide to Design, Analysis, and Reporting 1. Fundamentals of Trial Design

Module I: Clinical Trials a Practical Guide to Design, Analysis, and Reporting 1. Fundamentals of Trial Design Module I: Clinical Trials a Practical Guide to Design, Analysis, and Reporting 1. Fundamentals of Trial Design Randomized the Clinical Trails About the Uncontrolled Trails The protocol Development The

More information

THE IMPACT OF DATA VISUALIZATION IN A STUDY OF CHRONIC DISEASE

THE IMPACT OF DATA VISUALIZATION IN A STUDY OF CHRONIC DISEASE THE IMPACT OF DATA VISUALIZATION IN A STUDY OF CHRONIC DISEASE South Central SAS Users Group SAS Educational Forum 2007 Austin, TX Gabe Cano, Altarum Institute Brad Smith, Altarum Institute Paul Cuddihy,

More information

PharmaSUG Paper PO21

PharmaSUG Paper PO21 PharmaSUG 2015 - Paper PO21 Evaluating SDTM SUPP Domain For AdaM - Trash Can Or Buried Treasure Xiaopeng Li, Celerion, Lincoln, NE Yi Liu, Celerion, Lincoln, NE Chun Feng, Celerion, Lincoln, NE ABSTRACT

More information

Researcher 2: Post-Submission Advanced Topics

Researcher 2: Post-Submission Advanced Topics National Research Network Researcher 2: Post-Submission Advanced Topics IRBNet provides the research community with an unmatched set of secure, web-based collaboration tools to support the design, management,

More information

Automate Clinical Trial Data Issue Checking and Tracking

Automate Clinical Trial Data Issue Checking and Tracking PharmaSUG 2018 - Paper AD-31 ABSTRACT Automate Clinical Trial Data Issue Checking and Tracking Dale LeSueur and Krishna Avula, Regeneron Pharmaceuticals Inc. Well organized and properly cleaned data are

More information

Investigator Activities Quick Reference Guide. Sanofi/Genzyme October 2013

Investigator Activities Quick Reference Guide. Sanofi/Genzyme October 2013 Investigator Activities Quick Reference Guide Sanofi/Genzyme October 2013 Contents INVESTIGATOR ACTIVITIES QUICK REFERENCE GUIDE... 1 I. INTRODUCTION... 3 II. HOW TO REGISTER AND LOG IN... 6 III. HOW TO

More information

Optimization of Clinical Data Analysis

Optimization of Clinical Data Analysis Optimization of Clinical Data Analysis Hugues Gerard, Philippe Richardot, Robin Deransy, Marc-Antoine de Rotrou AR.R.I.S. Applications et Realisations de la Recherche Informatique et Statistique Keywords

More information

SAS Clinical Data Integration 2.6

SAS Clinical Data Integration 2.6 SAS Clinical Data Integration 2.6 User s Guide SAS Documentation The correct bibliographic citation for this manual is as follows: SAS Institute Inc. 2015. SAS Clinical Data Integration 2.6: User's Guide.

More information

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams CDASH MODEL 1.0 AND CDASHIG 2.0 Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams 1 What is CDASH? Clinical Data Acquisition Standards Harmonization (CDASH) Standards for the collection

More information

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on 2011-05-12 1 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical

More information

SAS IT Resource Management Forecasting. Setup Specification Document. A SAS White Paper

SAS IT Resource Management Forecasting. Setup Specification Document. A SAS White Paper SAS IT Resource Management Forecasting Setup Specification Document A SAS White Paper Table of Contents Introduction to SAS IT Resource Management Forecasting... 1 Getting Started with the SAS Enterprise

More information

Pooling Clinical Data: Key points and Pitfalls

Pooling Clinical Data: Key points and Pitfalls Paper DH01 Pooling Clinical Data: Key points and Pitfalls Florence Buchheit, Novartis, Basel, Switzerland ABSTRACT Pooling of clinical data is used by all Pharmaceutical companies. Submission to Health

More information

PharmaSUG Paper TT11

PharmaSUG Paper TT11 PharmaSUG 2014 - Paper TT11 What is the Definition of Global On-Demand Reporting within the Pharmaceutical Industry? Eric Kammer, Novartis Pharmaceuticals Corporation, East Hanover, NJ ABSTRACT It is not

More information

Introduction. Lesson 1 Access and Basic Navigation

Introduction. Lesson 1 Access and Basic Navigation Introduction Hello and Welcome to PRA s etmf Basics for External Users This tutorial is designed to provide you with a basic overview of PRA s etmf 3 System that you will be using to access your Trial

More information

Agile Master Data Management TM : Data Governance in Action. A whitepaper by First San Francisco Partners

Agile Master Data Management TM : Data Governance in Action. A whitepaper by First San Francisco Partners Agile Master Data Management TM : Data Governance in Action A whitepaper by First San Francisco Partners First San Francisco Partners Whitepaper Executive Summary What do data management, master data management,

More information

PharmaSUG Paper PO12

PharmaSUG Paper PO12 PharmaSUG 2015 - Paper PO12 ABSTRACT Utilizing SAS for Cross-Report Verification in a Clinical Trials Setting Daniel Szydlo, Fred Hutchinson Cancer Research Center, Seattle, WA Iraj Mohebalian, Fred Hutchinson

More information

PharmaSUG Paper PO03

PharmaSUG Paper PO03 PharmaSUG 2012 - Paper PO03 Streamlining Regulatory Submission with CDISC/ADaM Standards for Nonstandard Pharmacokinetic/Pharmacodynamic Analysis Datasets Xiaopeng Li, Celerion Inc., Lincoln, NE (USA)

More information

Introduction to using the CALERIE Public Use Database

Introduction to using the CALERIE Public Use Database Introduction to using the CALERIE Public Use Database Outline Where to find information Data download instructions Database installation Raw and Analysis datasets Important Data usage notes Major data

More information

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges

More information

WM2012 Conference, February 26 March 1, 2012, Phoenix, Arizona, USA. Groundwater Monitoring Report Generation Tools 12005

WM2012 Conference, February 26 March 1, 2012, Phoenix, Arizona, USA. Groundwater Monitoring Report Generation Tools 12005 Groundwater Monitoring Report Generation Tools 12005 Natalie López Savannah River Nuclear Solutions LLC, Aiken, South Carolina, 29808 ABSTRACT Compliance with National and State environmental regulations

More information

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA Paper FC02 SDTM, Plus or Minus Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT The CDISC Study Data Tabulation Model (SDTM) has become the industry standard for the regulatory submission

More information